Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001063683 | SCV001228542 | pathogenic | Bardet-Biedl syndrome 3; Retinitis pigmentosa 55 | 2023-12-17 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with arginine, which is basic and polar, at codon 31 of the ARL6 protein (p.Thr31Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Bardet–Biedl syndrome (PMID: 15314642). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 2044). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects ARL6 function (PMID: 19236846). For these reasons, this variant has been classified as Pathogenic. |
Institute of Human Genetics, |
RCV004814795 | SCV005071178 | pathogenic | Retinal dystrophy | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005024989 | SCV005659810 | likely pathogenic | Bardet-Biedl syndrome 1; Bardet-Biedl syndrome 3; Retinitis pigmentosa 55 | 2024-05-28 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000002125 | SCV000022283 | pathogenic | Bardet-Biedl syndrome 3 | 2004-09-01 | no assertion criteria provided | literature only |